Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.
about
Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.Targeting bromodomain and extraterminal proteins in breast cancer.Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.Overcoming resistance to DNA targeted agents by epigenetic activation of Schlafen 11 (SLFN11) expression with class I histone deacetylase inhibitors.Exploiting histone deacetylases for cancer therapy: from hematological malignancies to solid tumors.L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway.STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancerNovel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling
P2860
Q47212126-EA7F745F-2FD7-45CC-A4E5-1211715916A8Q47385983-DCF25A18-382E-4A13-BE1C-3A8CFA454713Q47805050-4CD673CD-9DF1-4A08-B5F5-DF0861C6E762Q49390599-5A40FA0B-F6E0-4A61-9251-7FC7A3ABE254Q51303168-960EE6F1-459C-4116-A679-CB6127C6BC3FQ52614677-7DA0F11A-97BC-4A93-A342-8B52ED36067FQ58778783-3D28AF46-42A5-4DDA-ADB7-9CB5BE73316DQ59138142-8A981955-2413-4A57-AF01-599F9081479F
P2860
Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Feedback Activation of Leukemi ...... e Inhibitors in Breast Cancer.
@en
type
label
Feedback Activation of Leukemi ...... e Inhibitors in Breast Cancer.
@en
prefLabel
Feedback Activation of Leukemi ...... e Inhibitors in Breast Cancer.
@en
P2093
P1433
P1476
Feedback Activation of Leukemi ...... se Inhibitors in Breast Cancer
@en
P2093
Hanlin Zeng
Meiyu Geng
Shuai Tang
Xiaojing Lan
Xiaotong Yang
P304
P356
10.1016/J.CCELL.2016.08.001
P577
2016-09-01T00:00:00Z